Drug class
Vaginal Anti-Infectives
Vaginal anti-infectives are a functional class of topical antimicrobial medications formulated as intravaginal creams, suppositories, ovules, or gels. Read more about Vaginal Anti-Infectives
23 drugs in this class 16 manufacturers
Drugs in Vaginal Anti-Infectives
METRONIDAZOLE
METRONIDAZOLE
CLINDAMYCIN PHOSPHATE
METRONIDAZOLE
Vaginal anti-infectives are a functional class of topical antimicrobial medications formulated as intravaginal creams, suppositories, ovules, or gels.
These agents exert localized antibacterial, antifungal, or antiprotozoal activity by disrupting pathogen cellular membranes, inhibiting nucleic acid or protein synthesis, or restoring physiological acidity within the vaginal vault.
Clinically, they are primarily indicated for treating lower female genital tract infections, most commonly vulvovaginal candidiasis, bacterial vaginosis, and symptomatic trichomoniasis.
By delivering therapeutic drug concentrations directly to affected mucosal tissues, they resolve local infection while minimizing systemic absorption and exposure.
-
molinahealthcare.com
Vaginal anti-infectives are a functional class of topical antimicrobial medications formulated as intravaginal creams, suppositories, ovules, or gels
-
drugs.com
Vaginal anti-infectives are a functional class of topical antimicrobial medications formulated as intravaginal creams, suppositories, ovules, or gels
-
fhi.no
Vaginal anti-infectives are a functional class of topical antimicrobial medications formulated as intravaginal creams, suppositories, ovules, or gels Clinically, they are primarily indicated for treating lower female genital tract infections, most commonly vulvovaginal candidiasis, bacterial vaginosis, and symptomatic trichomoniasis By delivering therapeutic drug concentrations directly to affected mucosal tissues, they resolve local infection while minimizing systemic absorption and exposure
-
nih.gov
These agents exert localized antibacterial, antifungal, or antiprotozoal activity by disrupting pathogen cellular membranes, inhibiting nucleic acid or protein synthesis, or restoring physiological acidity within the vaginal vault Clinically, they are primarily indicated for treating lower female genital tract infections, most commonly vulvovaginal candidiasis, bacterial vaginosis, and symptomatic trichomoniasis
-
fhi.no
These agents exert localized antibacterial, antifungal, or antiprotozoal activity by disrupting pathogen cellular membranes, inhibiting nucleic acid or protein synthesis, or restoring physiological acidity within the vaginal vault By delivering therapeutic drug concentrations directly to affected mucosal tissues, they resolve local infection while minimizing systemic absorption and exposure
-
drugbank.com
These agents exert localized antibacterial, antifungal, or antiprotozoal activity by disrupting pathogen cellular membranes, inhibiting nucleic acid or protein synthesis, or restoring physiological acidity within the vaginal vault
-
cdc.gov
Clinically, they are primarily indicated for treating lower female genital tract infections, most commonly vulvovaginal candidiasis, bacterial vaginosis, and symptomatic trichomoniasis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.